• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HARMAC MEDICAL PRODUCTS THERAKOS XTS PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HARMAC MEDICAL PRODUCTS THERAKOS XTS PHOTOPHERESIS SYSTEM Back to Search Results
Lot Number D732 - KIT
Device Problem Insufficient Information (3190)
Patient Problems Fainting (1847); Low Blood Pressure/ Hypotension (1914)
Event Date 01/25/2016
Event Type  Injury  
Manufacturer Narrative
This system was used for treatment.A review of kit lot d732 was performed.There were no nonconformances related to this complaint.This lot met release requirements.The uvadex lot number was not provided.However, a review of all uvadex lots manufactured since january 2013 was performed.No trends or nonconformances related to the complaint were noted.Trends were reviewed for complaint category fainting.No trend was identified for this issue.This assessment is based on information available at the time of the investigation.No product was returned by the customer for investigation; therefore, it could not be determined if this specific product met specification.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted through the capa/continuous improvement process.(b)(4).Device not returned.
 
Event Description
The patient fainted (for a duration of approximately 1 minute) while the clinical services specialist (css) was on site for training.This event occured during buffy coat in the 3rd of 4 cycles.The patients blood pressure dropped to 80/50.The treating physician administered 100 ml of saline and about 300 ml of electrolyte solution.The patient was brought into a vertical position and his blood pressure stabilized.Afterwards, the patient stated that he had not been feeling well all week but he had not mentioned this when asked about his well being prior to the start the extracorporeal photopheresis (ecp) treatment.Ecp was completed.The patient was monitored for several hours.No further episodes occurred.During css follow up it was confirmed that the patient remained stable and received an ecp treatment the next day without issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS XTS PHOTOPHERESIS SYSTEM
Type of Device
XTS
Manufacturer (Section D)
HARMAC MEDICAL PRODUCTS
2201 baily ave
buffalo NY 14211
Manufacturer (Section G)
HARMAC MEDICAL PRODUCTS
2201 baily ave
buffalo NY 14211
Manufacturer Contact
megan vernak
53 frontage road
hampton, NJ 08827
MDR Report Key5459043
MDR Text Key38983321
Report Number2523595-2016-00021
Device Sequence Number1
Product Code LNR
UDI-Device Identifier10705030100016
UDI-Public10705030100016
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/25/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Nurse
Device Expiration Date09/01/2020
Device Lot NumberD732 - KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/25/2016
Initial Date FDA Received02/24/2016
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient Weight64
-
-